1059 related articles for article (PubMed ID: 16055710)
1. Down-regulation of c-Fos/c-Jun AP-1 dimer activity by sumoylation.
Bossis G; Malnou CE; Farras R; Andermarcher E; Hipskind R; Rodriguez M; Schmidt D; Muller S; Jariel-Encontre I; Piechaczyk M
Mol Cell Biol; 2005 Aug; 25(16):6964-79. PubMed ID: 16055710
[TBL] [Abstract][Full Text] [Related]
2. c-Fos transcriptional activity stimulated by H-Ras-activated protein kinase distinct from JNK and ERK.
Deng T; Karin M
Nature; 1994 Sep; 371(6493):171-5. PubMed ID: 8072547
[TBL] [Abstract][Full Text] [Related]
3. Menin uncouples Elk-1, JunD and c-Jun phosphorylation from MAP kinase activation.
Gallo A; Cuozzo C; Esposito I; Maggiolini M; Bonofiglio D; Vivacqua A; Garramone M; Weiss C; Bohmann D; Musti AM
Oncogene; 2002 Sep; 21(42):6434-45. PubMed ID: 12226747
[TBL] [Abstract][Full Text] [Related]
4. A peptide fragment of ependymin neurotrophic factor uses protein kinase C and the mitogen-activated protein kinase pathway to activate c-Jun N-terminal kinase and a functional AP-1 containing c-Jun and c-Fos proteins in mouse NB2a cells.
Adams DS; Hasson B; Boyer-Boiteau A; El-Khishin A; Shashoua VE
J Neurosci Res; 2003 May; 72(3):405-16. PubMed ID: 12692907
[TBL] [Abstract][Full Text] [Related]
5. Up-regulation of TRPM6 transcriptional activity by AP-1 in renal epithelial cells.
Ikari A; Sanada A; Okude C; Sawada H; Yamazaki Y; Sugatani J; Miwa M
J Cell Physiol; 2010 Mar; 222(3):481-7. PubMed ID: 19937979
[TBL] [Abstract][Full Text] [Related]
6. B-ATF functions as a negative regulator of AP-1 mediated transcription and blocks cellular transformation by Ras and Fos.
Echlin DR; Tae HJ; Mitin N; Taparowsky EJ
Oncogene; 2000 Mar; 19(14):1752-63. PubMed ID: 10777209
[TBL] [Abstract][Full Text] [Related]
7. AP-1 transrepressing retinoic acid does not deplete coactivators or AP-1 monomers but may target specific Jun or Fos containing dimers.
Suzukawa K; Colburn NH
Oncogene; 2002 Mar; 21(14):2181-90. PubMed ID: 11948401
[TBL] [Abstract][Full Text] [Related]
8. Long-range electrostatic interactions influence the orientation of Fos-Jun binding at AP-1 sites.
Ramirez-Carrozzi VR; Kerppola TK
J Mol Biol; 2001 Jan; 305(3):411-27. PubMed ID: 11152600
[TBL] [Abstract][Full Text] [Related]
9. SUMOylation of the inducible (c-Fos:c-Jun)/AP-1 transcription complex occurs on target promoters to limit transcriptional activation.
Tempé D; Vives E; Brockly F; Brooks H; De Rossi S; Piechaczyk M; Bossis G
Oncogene; 2014 Feb; 33(7):921-7. PubMed ID: 23396363
[TBL] [Abstract][Full Text] [Related]
10. c-Jun and c-Fos cooperate with STAT3 in IL-6-induced transactivation of the IL-6 respone element (IRE).
Schuringa JJ; Timmer H; Luttickhuizen D; Vellenga E; Kruijer W
Cytokine; 2001 Apr; 14(2):78-87. PubMed ID: 11356008
[TBL] [Abstract][Full Text] [Related]
11. PACAP and C2-ceramide generate different AP-1 complexes through a MAP-kinase-dependent pathway: involvement of c-Fos in PACAP-induced Bcl-2 expression.
Aubert N; Falluel-Morel A; Vaudry D; Xifro X; Rodriguez-Alvarez J; Fisch C; de Jouffrey S; Lebigot JF; Fournier A; Vaudry H; Gonzalez BJ
J Neurochem; 2006 Nov; 99(4):1237-50. PubMed ID: 17026529
[TBL] [Abstract][Full Text] [Related]
12. Mechanism of action of a dominant-negative mutant of c-Jun.
Brown PH; Chen TK; Birrer MJ
Oncogene; 1994 Mar; 9(3):791-9. PubMed ID: 8108121
[TBL] [Abstract][Full Text] [Related]
13. The inhibitory activity of a transdominant c-jun mutant fused to the ligand binding domain of the estrogen receptor.
Kim S; Brown PH; Birrer MJ
Oncogene; 1996 Mar; 12(5):1043-53. PubMed ID: 8649795
[TBL] [Abstract][Full Text] [Related]
14. Structure and transcriptional regulation of BKJ, a novel AP-1 target gene activated during jun- or fos-induced fibroblast transformation.
Hartl M; Bister K
Oncogene; 1998 Dec; 17(22):2901-13. PubMed ID: 9879996
[TBL] [Abstract][Full Text] [Related]
15. Mechanism of AP-1-mediated gene expression by select organochlorines through the p38 MAPK pathway.
Frigo DE; Tang Y; Beckman BS; Scandurro AB; Alam J; Burow ME; McLachlan JA
Carcinogenesis; 2004 Feb; 25(2):249-61. PubMed ID: 14604893
[TBL] [Abstract][Full Text] [Related]
16. Oncogenic and transcriptional cooperation with Ha-Ras requires phosphorylation of c-Jun on serines 63 and 73.
Smeal T; Binetruy B; Mercola DA; Birrer M; Karin M
Nature; 1991 Dec; 354(6353):494-6. PubMed ID: 1749429
[TBL] [Abstract][Full Text] [Related]
17. Role of heterodimerization of c-Fos and Fra1 proteins in osteoclast differentiation.
Bakiri L; Takada Y; Radolf M; Eferl R; Yaniv M; Wagner EF; Matsuo K
Bone; 2007 Apr; 40(4):867-75. PubMed ID: 17189721
[TBL] [Abstract][Full Text] [Related]
18. High levels of phosphorylated c-Jun, Fra-1, Fra-2 and ATF-2 proteins correlate with malignant phenotypes in the multistage mouse skin carcinogenesis model.
Zoumpourlis V; Papassava P; Linardopoulos S; Gillespie D; Balmain A; Pintzas A
Oncogene; 2000 Aug; 19(35):4011-21. PubMed ID: 10962557
[TBL] [Abstract][Full Text] [Related]
19. Retinyl methyl ether down-regulates activator protein 1 transcriptional activation in breast cancer cells.
Agadir A; Shealy YF; Hill DL; Zhang X
Cancer Res; 1997 Aug; 57(16):3444-50. PubMed ID: 9270011
[TBL] [Abstract][Full Text] [Related]
20. Role of c-Jun concentration in neuronal cell death.
Rössler OG; Steinmüller L; Giehl KM; Thiel G
J Neurosci Res; 2002 Dec; 70(5):655-64. PubMed ID: 12424733
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
